论文部分内容阅读
目的观察分析氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床疗效。方法 96例高血压合并冠心病患者,随机分为观察组和对照组,每组48例。对照组给予阿托伐他汀钙片治疗,观察组给予氨氯地平阿托伐他汀钙片治疗,观察比较两组患者治疗前后的血压变化、血脂指标变化情况及临床疗效。结果治疗后两组患者收缩压、舒张压及各项血脂指标水平均明显优于治疗前,且观察组患者均明显优于对照组,差异具有统计学意义(P<0.05)。观察组治疗的总有效率为95.8%,明显高于对照组的81.3%,差异具有统计学意义(P<0.05)。结论高血压合并冠心病患者经氨氯地平阿托伐他汀钙片治疗,血压、血脂水平改善明显,疗效肯定,值得推广应用。
Objective To observe and analyze the clinical efficacy of amlodipine atorvastatin calcium in the treatment of patients with hypertension and coronary heart disease. Methods 96 patients with hypertension and coronary heart disease were randomly divided into observation group and control group, 48 cases in each group. The control group was given atorvastatin calcium tablets. The observation group was treated with amlodipine atorvastatin calcium tablets. The changes of blood pressure, blood lipid index and clinical efficacy were compared between the two groups before and after treatment. Results After treatment, systolic blood pressure, diastolic blood pressure and blood lipid levels were significantly better than those before treatment, and the patients in the observation group were significantly better than the control group, the difference was statistically significant (P <0.05). The total effective rate of the observation group was 95.8%, which was significantly higher than that of the control group (81.3%), the difference was statistically significant (P <0.05). Conclusion Patients with hypertension and coronary heart disease were treated with atorvastatin calcium tablets of amlodipine, blood pressure and blood lipid levels improved obviously, and the curative effect was definite, which is worth popularizing and applying.